Big, gnarly fava bean pods are in season right now, just as winter gives way from cool nights to bright, warm days. Heaps of the greens loved in the Middle East appear in the shouks (Arabic word for market): peas, string beans, asparagus, and for a short while, these fresh fava beans.

Somehow vegetables with short seasons excite the imagination and appetite more sharply than produce that’s available all year around. Good Middle Eastern cooks have many recipes for delicate fava beans, and this turmeric-fragrant soup is one.

Fresh beans are peeled twice: once when when you slide them out of their pods, and again when you squish each bean out from its rubbery covering. True; a little extra work. But it’s a restful task, and the soup is wonderfully herby, and redolent of green Springtime.

The preparation time listed relates to fresh beans. Frozen beans won’t need the peeling.

You’ll notice that the recipe calls for a fair amount of cilantro, but you can easily swap parsley for it if you prefer.

Fava Bean Soup Recipe

Ingredients

2 cups fresh or frozen fava bean pods
1 large leek, well washed and sliced ​​into thin rings (about 2 cups)
2 celery stalks sliced
2 carrots, sliced thinly
2 zucchini, diced
2 large potatoes, diced
2 tablespoons olive oil
1/2 teaspoon turmeric
1 teaspoon salt or more to taste
1/2 teaspoon black pepper
A bunch of coarsely chopped cilantro (about a cup)
8 cups/2 liters water or more as needed

Pull the strings off each pod and open it along the slit to expose the green beans. Use your thumbnail or a small knife. Push the beans out. Make a small cut in each bean, along the black stripe on its side, and squish it free of its sheath.

If using frozen beans, skip this step.
Heat olive oil in a deep pot over medium heat. Add the leeks, celery, carrots, zucchini and potatoes. Add turmeric, salt and black pepper, stir and let the vegetables cook gently for about 10 minutes, stirring occasionally.

Add 8 cups of water, stir and bring to a boil. Cook, covered, for 45 minutes over medium heat until all the vegetables are tender.

Add the peeled fava beans, bring back to a boil and continue cooking for another 45 minutes. Check the soup once or twice: if necessary, add a little water.

Using a potato masher, mash the vegetables very coarsely.

Taste for seasoning and add a little more salt and pepper if needed.

Turn off the heat and add a bunch of finely chopped cilantro or parsley.
Serve right away, and enjoy.

Love fava beans and want another recipe? Try this fava bean Iranian salad

The post Fresh Fava Bean Soup, A Vegan Springtime Recipe appeared first on Green Prophet.

Women’s health care is a vital component of public health, yet it remains one of the most under-addressed and misunderstood areas in medicine.

From adolescence through menopause and beyond, women face unique health challenges that call for specialised attention, informed care, and ongoing support. A strong medical team, one that includes both general practitioners and gynecologists, is key to ensuring women’s well-being across all stages of life.

This article explores why women’s health care matters, what comprehensive care looks like, and how evolving roles in medicine are helping to close gaps in access and quality.

The Complexity of Women’s Health

Women’s health is not limited to reproductive care. It encompasses a wide range of physical, mental, and emotional needs that are shaped by biological, social, and environmental factors. Women are more likely than men to experience autoimmune disorders, osteoporosis, and certain mental health conditions such as anxiety and depression. They also metabolize medication differently and may present atypical symptoms for conditions like heart disease, which has historically been underdiagnosed in women due to male-centric research models.

Reproductive health itself is multifaceted, involving menstrual health, contraception, fertility, pregnancy, childbirth, menopause, and gynecological cancers. These issues are deeply interconnected with other aspects of health. For example, untreated polycystic ovary syndrome (PCOS) can lead to insulin resistance and increase the risk of type 2 diabetes. Similarly, lack of access to prenatal care can result in complications for both mother and baby, including preterm birth and low birth weight.

Why a Strong Medical Team Matters

Navigating these complexities requires a coordinated, multidisciplinary approach. A good medical team doesn’t just treat symptoms; it builds relationships, monitors long-term health trends, and empowers women to make informed decisions.

Key members of this team include:

• General Practitioners (GPs): These providers offer routine checkups, manage chronic conditions, and serve as the first point of contact for most health concerns. They play a critical role in preventive care and early detection.
• Gynecologists: Specialists in reproductive health, gynecologists provide essential services such as Pap smears, breast exams, contraception counseling, and menopause management. Regular visits can lead to early diagnosis of conditions like cervical cancer or endometriosis.
• Advanced Practice Nurses: Nurses who have completed relevant programs can continue to specialize in areas like women’s health. Their advanced training equips them to deliver high-quality, patient-centered care and to serve as trusted members of a woman’s medical care team.
• Mental Health Professionals: Given the strong link between hormonal changes and mental health, therapists and psychiatrists are often vital in managing conditions like postpartum depression or premenstrual dysphoric disorder (PMDD).

This collaborative model ensures that women receive holistic care; care that sees the whole person, not just isolated symptoms.

The Power of Preventative Care

Preventive care is one of the most effective tools in women’s health. Annual wellness visits, mammograms, pap tests, and bone density scans can detect issues before they become serious.

According to the Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of death for women in the United States, yet many women are unaware of their risk factors. Regular checkups with a trusted provider can help monitor blood pressure, cholesterol, and lifestyle habits that contribute to cardiovascular health.

Vaccinations also play a key role. The HPV vaccine, for example, has significantly reduced the prevalence of the virus that causes most cervical cancers. Yet uptake remains uneven, especially in underserved communities. A well-informed medical team can help educate patients and ensure they receive timely immunizations to prevent disease.

Addressing Health Disparities

Despite the importance of women’s health care, access remains uneven across racial, geographic, and socioeconomic lines. Black women in the U.S. are three times more likely to die from pregnancy-related causes than white women. Native American women face higher rates of cervical cancer and lower screening rates. Rural women often struggle to find nearby providers, especially specialists.

These disparities reflect systemic issues that demand systemic solutions. Expanding telehealth services, increasing funding for community health centers, and supporting culturally competent care are all steps in the right direction. Nurses trained through flexible, accessible courses such as online DNP programs can help bridge these gaps by bringing advanced care to underserved areas and populations.

Building Trust and Communication

One of the most overlooked aspects of women’s health care is the importance of trust. Many women report feeling dismissed or not taken seriously by their providers, especially when discussing pain, fatigue, or mental health concerns. This can lead to delayed diagnoses and worsening outcomes.

A good medical team listens. They validate concerns, explain options clearly, and involve patients in decision-making. This kind of relationship is especially important in women’s health, where stigma and silence have historically surrounded topics like menstruation, sexual health, and menopause.

Advanced practice nurses often excel in this area. Their training emphasizes patient education, empathy, and long-term care relationships. Whether it’s helping a teenager navigate her first gynecological visit or supporting a woman through perimenopause, these professionals can offer both clinical expertise and emotional support.

Empowering Women Through Education

Health literacy is a powerful form of self-advocacy. When women understand their bodies, their risks, and their options, they’re better equipped to make informed decisions. This includes knowing when to seek care, how to interpret symptoms, and what questions to ask during appointments.

Medical teams that prioritize education through workshops, digital resources, or one-on-one counseling help empower women to take charge of their health. This is especially important in an era of misinformation, where social media can spread myths about everything from birth control to vaccines.

The Role of Nurses in Expanding Access

As the health care landscape evolves, nurses are playing an increasingly vital role in expanding access and improving quality. Nurses who have completed online DNP programs are uniquely positioned to specialize in women’s health and contribute meaningfully to care teams. Their advanced clinical training, combined with a focus on leadership and systems thinking, allows them to address both individual and community health needs.

These nurses often work in primary care settings, OB/GYN clinics, and community health centers, where they provide preventive services, manage chronic conditions, and offer reproductive health counseling. Their presence helps reduce wait times, improve patient satisfaction, and ensure continuity of care.

The future of women’s health care depends on our ability to build inclusive, responsive, and well-resourced systems. This means investing in research that reflects women’s experiences, training providers in gender-sensitive care, and expanding the roles of nurses and other professionals who can meet women where they are.

It also means recognizing that women’s health is not just a medical issue, it’s a social one. When women have access to comprehensive care, they are better able to participate in the workforce, care for their families, and contribute to their communities. Health equity for women is health equity for all. By prioritizing preventive care, addressing disparities, and fostering trust, we can build a health care system that truly supports women’s wellbeing through every stage of life.

The post Why Taking Care of Your Health as a Woman is So Important appeared first on Green Prophet.

How do you feel about you afterlife being a part of Kim Kardashian’s butt?

It sounds like a sustainable choice, from a sustainablist’s nightmare. With the excessive and dramatic use of the weight-loss Ozempec, and the gaunt look of a flattened butt and hollow face, more people are looking to liposuction to give more volume where gauntness has created a hole. It can happen in the cheeks, the hips, the rear-end. But not everyone can go through with the painful procedure of liposuction, when there is no fat to harvest.

A new Hollywood secret sauce is called alloClae and Miriam has written about it here. It’s a new injectable filler made from processed human donor fat. Unlike traditional fat grafting, which requires harvesting fat from a patient’s own body, alloClae offers fat “on demand,” purified and ready for injection for about $100,000 a syringe.

The fat is being positioned as a solution for patients who have lost so much weight that they no longer have enough fat for conventional contouring procedures.

Clinics in the US, and who knows where else, are increasingly using it to restore volume in the face, hips, and buttocks, areas most visibly affected by rapid weight loss. In effect, one intervention is being used to counterbalance another: pharmaceuticals to reduce fat, followed by biotech to replace it in more controlled ways.

The global rush to weight-loss drugs like Ozempic is reshaping bodies at unprecedented speed, and not always in ways people expect. While semaglutide (the generic name for Ozempec) has helped millions lose significant weight, and this can be good for the heart and the joints, researchers and clinicians are now documenting a set of unintended physical effects tied to rapid fat loss.  “Ozempic face” reflects accelerated volume loss in the cheeks and temples, producing a more aged appearance and literature describes this as “exaggerated volume loss… resulting in advanced facial aging.”

The impact is not limited to the face. Rapid weight loss has also been linked to reductions in lean mass, including muscle, raising concerns about long-term strength and metabolic health. At the same time, known side effects, ranging from nausea and gastrointestinal distress to more serious complications such as pancreatitis, continue to be studied as usage expands beyond diabetic populations.

According to Noor Saleem, approximately 15 million persons in the United States are currently taking GLP-1 drugs. Off-label use is becoming more common, which raises worries about potential health hazards and significant side effects such as non-arteritic anterior ischemic optic neuropathy (NAION), or vision problems.

Into this strange and dark landscape steps alloClae. From a macabre sustainability perspective, alloClae occupies an uneasy space. It can be framed as a form of biological reuse, drawing on donated tissue that might otherwise go unused.

Yet it also reflects a deeper shift toward the commodification of the human body (like facials made from baby parts), where fat becomes a standardized product moving through a supply chain. The pairing of Ozempic and alloClae signals something larger than a trend. I’d not want to donate my body for science, if there was a chance I could be a part of Kim Kardashian’s future butt. My friend Mike say otherwise: “F, yea. I’m in.”

Some other concerns, from Robert C, a literature professor in New York: “I hope it is possible to donate one’s body with stipulations that prevent some uses of it.”

Joy P, a business advisor says, “Horrific. A crucial reminder of the importance to place standards and controls alongside innovation; no matter how altruistic the intention, there seem always to be parasites waiting to profit from it.”

Liat C, a journalist in the US: “I think it is a disgusting desecration. I’m signed as an organ donor and I could even perceive of body fat being used for necessary plastic surgery for burn victims etc but not sold for someone’s cosmetic vanities and insanities.”

This all points to a future where bodies are increasingly engineered in stages, shaped by overlapping technologies that subtract, then add back, until the desired form is achieved.

I for one am staying natural. No botox, lasers or fillers for me. I will age, with grace or without. But some women build their self-esteem on their looks. For one user of alloclae, who didn’t show her face or give her real name in a recent article, she’s happy about it. She told the New York Post the alloClae treatment improves her self-esteem.

Karry R, a friend of mine from high-school, is concerned about the source of the cadaver fat. “Where is the honour in donating our bodies?” she tells me. “Our senior citizens think it’s for science.”

The post Fix your Ozempec face with alloClae fat from a human cadaver? appeared first on Green Prophet.

In this Ozempic age, a person may diet themselves down unattractive gauntness. Hip dips, bony shoulders, withered hands; not to mention drooping breasts and flat buttocks: a sad list of body parts needing plumping up to look good again.

“Personal fat banking” is a solution. A person set on losing a lot of weight can have their own fat harvested ahead of time via liposuction and later reinjected into any part of the body that needs a smooth contour. Expensive, but it can be done. Read here about plastic surgery’s environnmental impact.

But what happens when there’s no personal fat left to harvest?

Well, turn to fat harvested from dead people instead. Cadaver fat returns the bounce to the breasts just as efficiently as your own fat. As much as five kilos of fat may be harvested from a corpse. Certified agencies use male and female cadavers from 18-71 years old. The commercial name for processed human fat is Alloclae.

Cosmetic surgeons call it “regenerative medicine. ” Their websites may refer to “donated tissue,” if they mention the fat’s origins at all. To squeamish patients, they soothingly explain that AlloClae is part of a “biologic revolution.” It encourages the patient’s own cells to migrate into the donor matrix, rebuilding tissue.

That sounds so much more scientific, even sort of natural, doesn’t it? It sort of takes the uncomfortable dissonance away, unless you remember that the fat injected into your living body came from a dead person who never consented to its commercial use.

There is no proof that any donor, while living, gave informed consent for companies to make money off their remains; the remains they nobly donated to research and science, not for someone to fill out their bikini.

In fact, it’s not entirely clear if family members who agreed to donate their dear departed’s body are aware that someone may exploit it for sale. The original donors or their families typically do not profit.

Who’s making money from human fat in 2026?

The first parties are companies are known as “body brokers,” officially called non-transplant tissue banks. They acquire, dissect, and sell human bodies and body parts for medical research and education. They are intermediaries between the recently deceased and commercial buyers, such as medical device companies, military researchers, and private surgical training programs.

Tissue banks generate substantial revenue by “parting out” a single body; for instance, a head can fetch roughly $1,000, while a torso might be sold for several thousand dollars. A single corpse can generate up to $10,000 in total sales.

In the United States, no central registry for body brokers exists. Legitimate companies identify themselves as non-transplant tissue banks. If you look it up, you’ll find The American Association of Tissue Banks. They list accredited non-transplant anatomical donation organizations.

Biotech companies buy human fat from body brokers, then process and sterilize it. The finished product, Alloclae, is considered a legal and safe, FDA-compliant human cell and tissue product. It doesn’t technically have to be “approved” or “cleared” by the FDA, per the agency’s web site.

But unlike the organ transplant system, which is strictly regulated by the federal government, this industry operates with significantly less oversight.

Tiger Aesthetics, a subsidiary of the Tiger BioScience company, is the biggest processor of human fat in the USA . They claim that Alloclae, cleansed by detergents, is purified down to DNA residues that may provoke immunogenic response.

And so it may be. The process is still new enough that we don’t have long-term studies on possible secondary effects in patients injected with Alloclae.

The processed human fat is then sold on to specialized clinics and plastic surgeons. Those clinics and surgeons earn big fees for plumping up body parts of the rich and the vain. How much? It depends. Scanning the websites of several clinics, I saw quotes between US$5000 to US$7000 per syringe.

Dr. Sachin M. Shridharani offers the procedure at his Manhattan clinic, Luxurgery. Interviewed by The New York Post, he said that the procedures typically start at $10,000, with costs increase depending on the scope of treatment.

“If you want a full breast augmentation, hip dip and some buttock treatment and you have to use hundreds and hundreds and hundreds of cc’s of AlloClae, well, that’s going to cost tens of thousands of dollars.”

What you get for your money

Traditional fillers come in 1cc syringes, while AlloClae is packaged in much larger 12.5cc and 25cc sizes. This makes it a unique middle ground for “micro-augmentations” – fixing hip dips, “scooped-out” breasts, or post-liposuction dents that are too big for standard fillers but not large enough to justify surgery.

But the effects don’t last forever. While some claim that the “donated” fat is a sort of scaffolding for the patient’s own body to build up tissue, more often the lovely rounded effect wears away and dissolves after 18 months at longest.
Now that can’t be bad for business.

It gets darker.

Brokers frequently target low-income families by offering “free cremation” in exchange for the donation. In effect, the family agrees to sell their relative’s fat to pay for funeral costs. Some funeral directors maintain partnerships with body brokers to provide low-cost burials or cremations for poor families.

Investigations have uncovered instances of families being misled about how bodies would be used, as well as cases of improper handling, such as dismemberment with power tools or the sale of remains to gruesome “exhibits.”

Makes you wonder if any low-income cremations were empty coffins, while the deceased’s body was sold to independent body brokers.

Human Remains, The Newest Cosmetic

Science has given us many medical uses for bits and pieces of the human body. Lives are saved by heart, kidney, liver donations; parts of eyes, of skin, and more. These procedures come from a place of value for human life and dignity.

And maybe you know someone who’s had cosmetic surgery, or had it yourself. Why not; if surgery enhances a person’s appearance, makes them feel more confident and secure, and they can afford it, more power to them.

But would you get yourself injected with Alloclae?

The post The Next New Cosmetic: Human Fat Known as Alloclae appeared first on Green Prophet.

If you are the kind of person who heroically eats a few pounds of salmon every week, chases it with sardines, and lectures your friends about the virtues of oily fish, congratulations: you are doing the best thing for your body. 

In the modern nutrition universe, that level of commitment deserves an applause. But for those who don’t live in a Nordic fishing village, the nutrition company Zinzino has built its omega-3 research and formulations around these principles, combining biomarker testing, antioxidant protection and traceable sourcing across both sustainably harvested small-fish oils and a vegan marine-microalgae alternative. It’s biohacking at the next level. 

They explain why: Because omega-3 fatty acids, the famous EPA and DHA found in marine foods, remain among the most important structural fats in the human body. They support brain signaling, heart health, immune balance and cellular communication. Unlike trendy nutrients that cycle through wellness blogs, omega-3 has survived decades of scientific scrutiny.

But here is the catch: most people are not eating enough of the right seafood. And supplement companies may be giving you confusing information.

Walk into any health store and you’ll see shelves lined with omega-3 oils promising brain health, heart health, joint support and more. Yet not all omega-3s are created equal, and the differences go far beyond price or flavor. You might assume the best oils are the ones that taste the strongest or come from the coldest waters on Earth. But before you shop, it helps to understand what you’re actually getting. Where does the oil come from? Is fishing sustainable? Can vegan sources really replace fish? And does the body actually absorb what’s written on the label?

These questions sit at the intersection of environmental integrity, science-backed innovation and sustainability and we ask these questions today to a company that makes the gold standard omega-3 for pescetarians and vegans. 

Founded in Norway and headquartered in Sweden, Zinzino approaches omega-3 as both a nutritional and biochemical challenge. Rather than simply sourcing oil and labeling it, the company focuses on how to deliver EPA and DHA in a form the body can actually use while protecting fragile fatty acids from oxidation.

Think Mediterranean oil-pressing traditions adapted to modern nutrition science.

Its BalanceOil+ blends purified oil from small wild-caught fish such as sardines, mackerel and anchovies with cold-pressed extra-virgin olive oil rich in early-harvest polyphenols. Small fish, they say,  are less likely to accumulate heavy metals from the food chain. The olive oil antioxidants come from Picual olives grown in Spain and Koroneiki olives from Cyprus, creating a protective environment for the omega-3 while supporting absorption. 

Recently Emmalee Gisslevik, PhD, Senior Research & Development Specialist – BalanceOil, spoke to Green Prophet to talk about environmental integrity, science-backed innovation and sustainability, and how omega-3 supplements are evolving alongside these priorities.

Omega-3 science, algae versus fish, and why quality, source and oxidation protection may matter more than most people realize. Below is our conversation.

Let’s start simple: why are omega-3s still such a big deal nutritionally today?

Because omega-3s are not just fashionable nutrients—they are structurally important fats that are incorporated into cell membranes throughout the body to facilitate key functions in the body such as heart, brain and immune health. The long-chain marine omega-3s, EPA and DHA, are especially relevant because they are the biologically active forms most closely linked to established physiological functions, while the body converts only limited amounts from plant omega-3 (ALA). They also remain highly relevant today because many people do not eat oily fish regularly, even though marine foods are still the main dietary source of EPA and DHA. So from a practical nutrition perspective, omega-3 remains important because intake is often inconsistent, while the physiological need does not disappear.

Many people assume eating fish once in a while is enough. From your research, when does supplementation actually make sense?

Eating fish is a very good strategy—but ‘once in a while’ is not the same as consistently reaching the usual target of about two servings of fish per week. Supplementation makes the most sense when seafood intake is low or irregular, when someone avoids fish, follows a vegan diet, wants a more standardized daily intake, or wants to check whether their actual omega-3 status matches what they think they are getting from food. In practice, this is where testing becomes useful: it moves the conversation from assumptions to actual biological status.

Zinzino offers both fish-derived and vegan omega-3. From a biological perspective, do they deliver comparable EPA and DHA? And what’s the price point compared to other oils?

From a biological perspective, the key question is how much EPA and DHA the product delivers—not whether the source is fish or microalgae. In Zinzino’s standard 12 ml serving, BalanceOil+ provides about 2.0 g EPA+DHA (approximately 1.3 g EPA + 0.7 g DHA), while BalanceOil+ Vegan provides about 1.9 g EPA+DHA (approximately 0.8 g EPA + 1.1 g DHA), and with SDA for endogenous production of EPA. So the total long-chain omega-3 delivery is broadly comparable, although the profile differs. The fish-based version is more EPA-forward, while the vegan version is more DHA-forward. That distinction can matter depending on what aspect of omega-3 nutrition you want to emphasize, but both are designed to deliver meaningful amounts of long-chain marine-type omega-3. One challenge with vegan formulations is achieving robust EPA delivery, because many algae oils are naturally more DHA-rich than EPA-rich. 

Our vegan formulation addresses that by combining microalgal oil with Ahiflower® oil, which contains SDA—an omega-3 fatty acid that converts to EPA more efficiently than ALA does. Combined with olive oil, this creates a broader fatty acid strategy than a simple single-source algae oil. From a pricing perspective, vegan omega-3 oils are typically more expensive than standard fish-based omega-3 oils, largely because microalgal EPA/DHA production is still costlier and more technologically controlled. In practice, that means the vegan option is usually positioned as a premium product.

Sustainability is a major concern for our readers. How do you ensure your fish oil sourcing doesn’t contribute to overfishing or marine damage?

Using sustainably sourced, natural ingredients is an essential part of our brand’s core values. We strongly believe that to maintain balance in our body, we also have to respect the balance of the planet and its resources. Our omega-3 supplement is certified by Friend of the Sea, the global certification standard for upholding a sustainable marine environment, Zinzino was first certified by Friend of the Sea in 2018 and we have since maintained our commitment towards sustainability. The fish oils used by Zinzino are derived from short-lived, wild-caught fish, harvested by sustainable fisheries in authorized areas, and following the Friend of the Sea criteria.   

Vegan omega-3 often comes from algae, essentially the original source of marine omega-3. What makes microalgae oil effective compared to plant oils like flax or chia? How do we know that the algae is clean and free from microplastics and PFASs?

Microalgae oil is effective because it provides preformed EPA and DHA directly. By contrast, flax and chia mainly provide ALA, which is nutritionally valuable, but the body converts only a limited amount of ALA into EPA—and very little into DHA. So if the goal is specifically to increase long-chain omega-3 status, microalgae offers a more direct and efficient route. In terms of purity, one important advantage is that microalgae is cultivated in controlled production systems rather than harvested from open marine ecosystems. That gives much tighter control over sourcing, consistency, and raw material quality.

Your formulations combine omega-3 with early-harvest olive polyphenols. This isn’t common in most supplements? What problem does this solve? Or how do you stand out in this regard. 

This solves a real formulation problem: Omega-3s are delicate—they can break down and go rancid pretty easily. So instead of just putting omega-3 into a capsule on its own, we pair it with extra-virgin olive oil that’s rich in natural antioxidants; polyphenols. That way, we’re not simply adding “another oil”—we’re building extra protection right into the blend.

Those olive polyphenols help defend the omega-3s against oxidation, and the olive oil also changes the overall fat environment in a way that’s more supportive than a basic fish oil or algae oil by itself. The goal is simple: help keep these sensitive fatty acids more stable, both in the product and once you’ve taken it. That’s one of the ways our formula stands out. We don’t treat omega-3 as a standalone ingredient—we build it into a more complete fat system designed for stability, function, and context.

Third-party certifications: Friend of the Sea, Informed Sport, Cologne List, The Vegan Society, Halal, GMP, EU and EFSA. Tell us how difficult it is to get some of these certifications. 

Some third-party certifications are relatively straightforward if your documentation is solid and your suppliers are well organized — while others are genuinely demanding because they require ongoing testing, deep traceability, or even regulatory-level scientific evidence. The toughest ones tend to be “continuous-control” programs. Informed Sport is a great example: it’s considered difficult because it typically involves rigorous quality requirements and regular batch testing for banned substances, not just a one-time audit. Cologne List can also be demanding in practice because products are often tested and listed by batch, which means you need consistency and repeat testing to stay current.

Audit- and traceability-based certifications sit in the middle — but can become hard with complex supply chains. Friend of the Sea usually requires strong sourcing transparency and traceability (sometimes through multiple suppliers). GMP can be smooth if your manufacturer already runs a mature quality system — but if not, it can take real work to build the documentation, procedures, training, and audit readiness needed. Ingredient- and process-driven labels are very achievable — as long as you can prove what’s in (and not in) the product. The Vegan Society and Halal typically hinge on ingredient verification, supplier declarations, and preventing cross-contact in production (especially if lines are shared with non-vegan or non-halal materials). They’re very doable, but they get more complex when you have lots of raw materials or shared facilities.

And a quick nuance: “EU and EFSA” aren’t really certifications like the others — they’re regulatory frameworks. If you mean getting an EFSA-backed health claim approved in the EU, that’s usually one of the hardest routes because it requires a formal scientific dossier and a high standard of evidence.

 Fun but honest question: if someone says, “I hate fish and I don’t trust supplements,” – I get my nutrition from eating a kilo of salmon a week. And I buy sardines. Real food is the best. What would you tell them?

If you hate fish but are still heroically eating a kilo of salmon a week and buying sardines, then you are already doing the hard part. Regular intake of oily fish is the gold-standard way to get preformed marine omega-3. That is the ideal, and it is the most natural and biologically complete way to obtain EPA and DHA. So to me, this is not really an argument about food versus supplements. 

The real question is whether a person’s life and habits actually allow them to eat enough quality fish, consistently enough, to reach the blood levels they want. If that works, that is the superior option. If not, a well-designed supplement can help close that gap. And if your relationship with fish is a little on-and-off, it is good to know there are well-designed alternatives— and if you are skeptical, there are blood tests that can tell you whether they are truly effective for you.

How and where do we find your products in America, Canada, Europe and the rest of the world? 

Zinzino’s products are not available for sale in retail stores because better health is personal, and all bodies are unique. Getting individual guidance is critical for a successful outcome. We want to connect with customers directly, build trust, understanding and mutual respect, and offer personalized solutions tailored to meet their specific needs and goals. 

To this end, all our products are sold exclusively through a Zinzino Independent Partner who will join the customers on their health journey. We currently have at least 50 000 working at markets across the globe, and you may find the one nearest you on zinzino.com

Tell us more about the blood sampling and how and if biohackers can get involved? I know people who’d like to share that data. 

The blood sampling is a finger-prick dried blood spot test that can be done at home. The current BalanceTest measures 11 fatty acids, does not require fasting, and you register it online using an anonymous test code. That makes it practical for repeat use and for before-and-after comparisons over time to monitor your body’s response to changes in diet and lifestyle. What makes it interesting to data-driven users is that it does not only report absolute omega-3-related values.

 It also looks at the relationship between different fatty acid groups—for example, the balance between long-chain omega-3s and other fats—and includes calculated markers that help summarize different aspects of fatty acid status. For biohackers, that means it can be used as a structured feedback tool: test, adjust diet or supplementation, and retest after a meaningful interval. If people want to share their data, the important part is that this should be done through a clear, consent-based framework, with appropriate respect for privacy and data handling. That is where personal experimentation can become genuinely useful rather than just anecdotal.

::Zinzino

The post Fish or Vegan Omega-3? Does quality, source and science matter more than you think? appeared first on Green Prophet.

People whose drinking water came from newer groundwater had a higher risk of developing Parkinson’s disease than those whose drinking water came from older groundwater, according to a preliminary study released March 2, 2026, that will be presented at the American Academy of Neurology’s 78th Annual Meeting taking place April 18–22, 2026, in Chicago and online.

The study does not prove that newer groundwater causes Parkinson’s disease; it only shows an association.

The research focused on the age of groundwater and the aquifers that supply it. An aquifer is an underground layer of porous rock, silt, or sand that stores and transports groundwater. Scientists increasingly see water sources as a window into long-term environmental exposures.

“One way to examine our exposure to modern pollution is through our drinking water,” said study author Brittany Krzyzanowski, PhD, of the Atria Research Institute in New York City, who conducted the research while at the Barrow Neurological Institute. “Newer groundwater, created by precipitation that has fallen within the past 70 to 75 years, has been exposed to more pollutants. Older groundwater typically contains fewer contaminants because it is generally deeper and better shielded from surface contaminants. Our study found that groundwater age and location is a potential environmental risk factor of Parkinson’s disease.”

The study analyzed data from 12,370 people with Parkinson’s disease and more than 1.2 million people without the disease, matched for age, sex, race, and ethnicity. All participants lived within three miles of 1,279 groundwater sampling sites across 21 major U.S. aquifers.

A case for raw water from ancient sources

Researchers examined groundwater age, aquifer type, and drinking water source—such as municipal groundwater systems or private wells—as indicators of possible exposure to neurotoxic contaminants.

Two types of aquifers stood out. Carbonate aquifers, made mostly of limestone, often allow water to move quickly through fractures, making them more vulnerable to surface contamination. Glacial aquifers, formed more than 12,000 years ago as glaciers advanced and retreated, are composed of sand and gravel that can naturally filter water as it moves underground.

After adjusting for factors such as age, sex, income, and air pollution, people whose drinking water came from carbonate aquifers had a 24% higher risk of developing Parkinson’s disease compared with those whose water came from other aquifers. When compared specifically with people whose water came from glacial aquifers, the risk was 62% higher.

Researchers also found that older groundwater appeared to have a protective effect in carbonate aquifers. For each increase in groundwater age, the risk of Parkinson’s disease declined by about 6.5%. In contrast, groundwater formed in the past 75 years in carbonate systems was linked to an 11% higher risk compared to water dating back to the ice age.

“We speculate that the apparent protective effect of older groundwater is seen mainly in carbonate aquifers because these systems can show a clearer contrast between newer and older water,” said Krzyzanowski. “In these aquifers, newly recharged groundwater is more vulnerable to surface contamination, while older groundwater can remain cleaner if it is separated from recent inputs by a confining layer.”

“In contrast, glacial aquifers tend to slow groundwater movement and naturally filter contaminants as water travels underground,” she added.

The findings highlight how where drinking water comes from may matter for long-term health. People can often learn about their water source through local utilities or regional groundwater agencies. For households using private wells, testing water periodically and considering filtration systems can help reduce potential exposure to contaminants.

“This study highlights that where our water comes from, including the age of groundwater and the type of water source, could shape long-term neurological health,” said Krzyzanowski. “While additional research is needed, bringing together knowledge about groundwater and brain health may help communities better assess and reduce environmental risks.”

The post Is your groundwater too young? New study finds risks for Parkinson’s and type of water you drink appeared first on Green Prophet.

For the one in three (98 million) Americans living with prediabetes, a surprising fresh fruit pairing may hold promise for heart health. A new study published in the Journal of the American Heart Association suggests that adding one avocado and a cup of mango to your daily routine may help support key markers of cardiovascular health.

Adults with prediabetes who enjoyed this combination daily for eight weeks saw improvements in blood vessel function and diastolic blood pressure – two important indicators of cardiovascular wellness.

Conducted by researchers at Illinois Institute of Technology (Illinois Tech), the study asked adults with prediabetes to follow an Avocado-Mango (AM) diet – adding one medium Hass avocado and a cup of fresh mango to their daily meals and snacks for eight weeks. A calorie-matched control group followed a similar diet, with avocado and mango replaced by calorically comparable carbohydrate-based foods. Those on the AM diet saw meaningful improvements in blood vessel function, which supports healthy circulation, and diastolic blood pressure, a key factor in long-term heart health, compared to the control group.

Blood vessel function improved significantly in participants on the AM diet. They experienced a significant increase in flow-mediated dilation (FMD) – a key measure of endothelial function (blood vessel health) – to 6.7%, compared with a decline to 4.6% in the control. This suggests a meaningful improvement.

Diastolic blood pressure also significantly improved, particularly among men. In the control group, men saw an average central blood pressure increase of 5 points (mmHg), while those on the AM diet experienced a reduction of about 1.9 points – a difference that can be clinically significant if sustained. These benefits occurred without changes in calorie intake or body weight, suggesting that nutrient-dense fruits like avocado and mango may support cardiovascular health without major lifestyle changes.

“This research reinforces the power of food-first strategies to help reduce cardiovascular disease risk, particularly in vulnerable populations like those with prediabetes,” said Britt Burton-Freeman, PhD, Principal Investigator and Professor at Illinois Tech. “It’s an encouraging message: small, nutrient-dense additions—like incorporating avocado and mango into meals and snacks—may support heart health without the need for strict rules or major dietary overhauls.”

The Avocado-Mango group also saw increases in fiber, vitamin C, and heart-healthy monounsaturated fat – nutrients tied to cardiovascular wellness – without changes in calorie intake or body weight. Select kidney function markers, such as estimated glomerular filtration rate (eGFR), also improved.

While no significant differences were found in cholesterol, blood sugar, or inflammation, the findings highlight the value of adding nutrient-rich fruits to the diet, especially for those at risk of type 2 diabetes and cardiovascular disease.

The post Mango and avocado combine for heart health appeared first on Green Prophet.

Short-term surges in air pollution in New Jersey from the 2023 Canadian wildfires were associated with a higher stroke rate and more serious strokes, according to a preliminary study released March 3, 2026, that will be presented at the American Academy of Neurology’s 78^th Annual Meeting next month.

“Wildfire smoke contains pollutants like ozone and particulate matter, so it is more than a nuisance, it can be a public health hazard,” said study author Elizabeth Cerceo, MD, of Cooper Medical School of Rowan University in Camden, New Jersey. “The 2023 Canadian wildfires resulted in unprecedented declines in air quality across the northeastern United States. Our findings show that short-term exposure to elevated air pollution from these wildfires was associated with a higher incidence and severity of stroke.” 

Related: smoking and strokes

For the study, researchers used a stroke registry to identify all cases of stroke that occurred during June and July 2023 and during the same months a year earlier. Ischemic strokes are the most common kind of stroke. Bleeding strokes are more severe and often more fatal.

Researchers reviewed U.S. Environmental Protection Agency data for both periods from air quality monitors located in Camden, New Jersey. They calculated average daily exposures for ozone which, when inhaled, can cause shortness of breath, coughing and aggravation of conditions like asthma. They also calculated daily average exposures for fine particulate matter, also called PM2.5, which is air pollution with particles that are 2.5 micrometers in diameter or less.

Ozone levels peaked at 136 parts per billion (ppb) during the wildfires in 2023 compared to median ozone concentration of 36 ppb. Particulate matter reached 211 micrograms per cubic meter (µg/m³) compared to median concentration of 48.5 µg/m³.

Daily air quality data was matched with the timing of each stroke. Because pollution effects may take a few days to impact the body, researchers also took into account the levels from the preceding one to two days before participants had their stroke.

For ozone levels, 72% of the days were 50 ppb or less, with 28% of the days above the recommended level. The World Health Organization guideline for ozone is 50 ppb. Researchers compared 42 strokes that occurred on above average ozone days, with 80 strokes that occurred on below average days. For strokes that occurred on above average ozone days, the incidence of stroke, or the rate at which new stroke cases occurred, was 1.25 strokes per day compared to 0.93 strokes per day that occurred on below average days.

After adjusting for factors like age, sex, race, and cause of stroke, researchers found higher average ozone days were associated with a 0.32 higher incidence of stroke per day.

They also found for strokes on above average ozone days, there was a higher proportion of bleeding strokes and more large artery atherosclerosis, plaque buildup in major arteries.

For particulate matter levels, 38% of the days were above average days and 62% were below average days. Researchers compared 39 strokes that occurred on above average particulate matter days to 83 strokes that occurred on below average days. They found above average particulate matter was associated with longer hospital stays and higher scores on a scale measuring stroke severity.

“While longer-term air pollution has been recognized as a risk factor for stroke, less is known about short exposures to wildfire smoke,” said Cerceo. “Our study addresses a critical gap by providing more information about the neurological impact of wildfire smoke. Our findings can help guide stroke prevention and underscore the need for public health interventions during wildfires.”

The post Exposure to wildfire smoke leads to strokes appeared first on Green Prophet.

One hallmark of Justin Trudeau’s leadership in Canada was legalizing cannabis, making it legal to buy it at shops and dispensaries even without a doctor’s note. That act has made accessibility to cannabis commonplace and within reach for teens too, who are fond of gummies and edibles. But cannabis can hurt developing brains, and it’s not only providing pain relief and therapy. While it can calm symptoms of PTSD, it can also lead to negative outcomes such as anxiety and depression, finds a new study.

The study looked at 35,000 Canadians who use cannabis and shows that rising cannabis use and worsening mental-health symptoms are increasingly appearing together, with the connection between the two strengthening over time.

The study, led by McMaster University, was published in The Canadian Journal of Psychiatry and analyzed data from two large, nationally representative Statistics Canada surveys of Canadians aged 15 and older living in the provinces, to examine cannabis use and mental-health outcomes between 2012 and 2022.

With the legalization of cannabis in Canada landing at the midpoint of the study period, the authors suggest that stronger products, wider availability, and increased use for stress relief may be contributing to the patterns they observed. The study doesn’t prove causation, but it underscores a widening public-health issue as cannabis use and mental-health challenges rise in parallel.

“We see that Canadians who use cannabis tend to be more likely to meet criteria for anxiety and depressive disorders, and more likely to report suicidality. We also see that this co-occurrence has strengthened over time,” said Jillian Halladay, an assistant professor who contributed to the study.

Key findings:

• The number of people reporting generalized anxiety disorder and major depressive episode nearly doubled, increasing to 5.2% and 7.6%, respectively.

• Suicidality didn’t change much in adults but increased by 44% among youth. Younger Canadians also saw some of the strongest cannabis–mental-health connections.

• Canadians who used cannabis at any level, compared to those who did not, were more likely to meet criteria for generalized anxiety disorder and major depressive episode and report suicidality. The connection between cannabis use and these mental-health problems strengthened over time.

• In 2022, Canadians who used cannabis regularly (two or more times a week) were about five times more likely to report anxiety, depression, or suicidality than those who did not use cannabis.

“This extends our prior study that similarly found a strengthening in the co-occurrence of cannabis use and these mental-health problems between 2002 and 2012,” she says.

Halladay and her fellow researchers emphasize that the growing overlap between cannabis use and mental-health problems highlights the need for earlier detection of anxiety, depression, and suicidality among people who use cannabis, as well as routine screening for cannabis use in mental-health settings.

“It’s important for people to recognize when and how their cannabis use may be impacting their mental health, and how their mental health may be influencing their cannabis use. It’s also increasingly important for health and mental-health providers to assess and address both cannabis use and mental-health concerns together.”

This study furthers recent research from McMaster that found anxiety and depression rates among teenagers increased nearly three-fold over the last decade. In that study, rates of anxiety and depression were higher in teens who use cannabis heavily.

The post Cannabis use linked to anxiety and depression appeared first on Green Prophet.

The question of what constitutes safe artificial turf has generated substantial debate among athletic directors, facility managers, and sports medicine professionals. While synthetic playing surfaces have transformed the landscape of organized athletics over the past six decades, the conversation around player protection has matured significantly. Today, independent university research and standardized testing protocols offer concrete answers about which technologies and design principles deliver the strongest safety outcomes for athletes.

A comprehensive analysis published by AstroTurf experts on turf field safety identifies several critical factors that separate premium synthetic surfaces from standard installations. Chief among these factors is infill stabilization technology, which addresses one of the most persistent challenges in synthetic turf performance: the migration of granular materials away from high-traffic areas toward less-used zones of the playing field.

The Science Behind Impact Attenuation

Player protection on any athletic surface begins with the field’s ability to absorb and disperse kinetic energy when athletes fall or make contact with the ground. The American Society for Testing and Materials developed GMAX testing protocols that have served as the industry standard for measuring this impact attenuation capability for more than three decades.

Under ASTM F355 Procedure A and ASTM F1936 specifications, a 20-pound missile is dropped from a height of 24 inches at multiple locations across a field, measuring the surface’s response to simulated athlete impacts. The maximum allowable GMAX value stands at 200 G’s according to ASTM guidelines, though the Synthetic Turf Council and NFL mandate more conservative thresholds of 165 G’s for professional applications. Premium synthetic turf systems targeting natural grass equivalence maintain GMAX values between 90 and 115 G’s, matching the shock absorption characteristics of well-maintained professional fields.

The significance of these measurements extends beyond abstract numbers. Research indicates that approximately 17.5 percent of concussions sustained by student athletes result from contact with playing surfaces rather than collisions with other players. This statistic, drawn from a study conducted by researchers at the University of North Carolina at Chapel Hill, underscores why consistent impact attenuation across an entire playing surface matters for athlete welfare.

University Research Validates Safety Technologies

The most credible safety claims in the synthetic turf industry trace back to peer-reviewed research conducted at accredited academic institutions. AstroTurf has invested millions of dollars in research partnerships that have produced measurable improvements in understanding surface-athlete interactions.

The University of Tennessee’s Center for Athletic Field Safety represents what researchers describe as the single largest athletic field research effort ever undertaken. The facility comprises 60 small-scale athletic research fields constructed from various playing surfaces, enabling scientists to conduct both mechanical and human studies under realistic playing conditions. Dr. John Sorochan, Distinguished Professor and Director of the center, has stated that the facility’s primary goal is to make fields safer at all levels of play.

The collaborative research has directly influenced product development strategies, steering the company’s offerings toward matching and surpassing professionally maintained natural grass. This natural grass benchmark serves as the gold standard because it represents the surface characteristics that athletes’ bodies have adapted to over generations of organized sports.

Independent research conducted at Michigan State University examined biomechanical properties across multiple synthetic turf systems. The study identified the proprietary AstroTurf RootZone technology as “the most influential variable” in reducing torque transmitted to lower extremities because it “limited cleat contact with the infill and provided a less compacted infill layer.” These findings carry particular weight because the research was independently funded, eliminating potential bias from manufacturer-sponsored studies.

How Infill Stabilization Addresses Surface Consistency

Infill migration presents one of the most significant maintenance challenges in synthetic turf management. During intensive play, traditional surfaces experience movement of sand and rubber granular materials from goal areas, sidelines, and other high-use zones toward the perimeter of the field. This migration creates unpredictable surface behavior precisely where athletes need consistent conditions the most.

The engineering solution developed by AstroTurf involves crimped nylon fibers that create a three-dimensional matrix beneath the playing surface. This matrix encapsulates infill material and prevents migration during play, maintaining uniform shock absorption and traction characteristics across the entire field throughout the product’s operational lifespan.

When infill remains stable, athletes experience predictable surface behavior that allows confident planting, cutting, and directional changes. This predictability reduces the unexpected variations that contribute to lower extremity injuries, including ACL tears and ankle sprains. The consistency factor proves especially important during the later stages of games when fatigue may compromise an athlete’s ability to compensate for inconsistent surface conditions.

Testing Standards Beyond Basic Impact Assessment

While GMAX testing provides essential information about shock absorption, a comprehensive safety evaluation requires multiple assessment methods. The FIFA Quality Programme establishes rigorous testing criteria that examine ball roll, bounce characteristics, energy restitution, vertical deformation, and rotational resistance alongside impact attenuation measurements.

FIFA’s 2024 update to its Test Manual introduced the Head Injury Criterion 1000 test, which assesses a surface’s ability to mitigate high-energy impacts by establishing a minimum critical fall height requirement of 0.60 meters. This addition reflects growing attention to head injury prevention in professional athletics and demonstrates how international governing bodies continue to raise performance benchmarks.

The synthetic turf manufacturer based in Dalton, Georgia, subjects its systems to One Turf testing protocols, which industry professionals consider the gold standard in comprehensive turf evaluation. This testing framework aligns with standards from FIFA, World Rugby, and the International Hockey Federation simultaneously, ensuring products meet requirements across multiple sports applications.

In-house testing facilities equipped with Berlin Athletes machines, QUV weathering testers, and accelerated wear simulators enable validation before field deployment rather than relying solely on post-installation assessment. This pre-market validation approach ensures innovations translate to real-world performance improvements.

Advanced Fiber Technologies Contribute to Player Protection

The fibers comprising an artificial turf surface play a substantial role in safety performance beyond their primary function of supporting athletic activity. Modern fiber technologies address concerns ranging from surface abrasiveness to thermal management.

Sharkskin technology reduces skin friction, addressing turf burn concerns that have historically affected athletes in sliding sports. The integration of antistatic additives reduces static electricity by substantial margins compared to standard fibers, which helps maintain infill stability during dry conditions when particle migration would otherwise increase.

Temperature management innovations respond to concerns about surface heat, particularly for facilities in warmer climates or those with limited shade coverage. Advanced polymer formulations incorporating thermal shield technology reduce the rate at which fibers absorb heat, enhancing athlete comfort while simultaneously extending fiber lifespan by reducing thermal degradation.

Antimicrobial treatments eliminate bacterial odors and prevent microbial buildup on fiber surfaces, contributing to healthier playing environments, particularly relevant for multi-use facilities where surfaces experience intensive daily use across various user groups.

The Multifactorial Nature of Athletic Injuries

Responsible discussion of playing surface safety acknowledges that turf represents one variable among many in athletic injury prevention. Player conditioning, footwear selection, weather conditions, game intensity, fatigue levels, and individual biomechanics all contribute to injury patterns observed in organized athletics.

Dr. James Voos, Chair of the Orthopedics Departments at University Hospitals and Case Western Reserve, has emphasized the importance of educating athletes on proper footwear selection while noting that schools must adequately maintain turf surfaces to appropriate quality standards. This perspective reflects the consensus view among sports medicine professionals that injury prevention requires attention to multiple interconnected factors.

Premium synthetic surfaces provide consistent, predictable playing environments that remove surface variability from the equation. Athletes who trust the ground beneath them can focus on performance rather than compensating for unpredictable conditions, which itself represents a safety benefit beyond measurable shock absorption metrics.

Manufacturing Quality and Vertical Integration

The consistency of safety characteristics depends on the reliable execution of design specifications throughout manufacturing and installation processes. AstroTurf controls all manufacturing and installation processes from initial polymer formulation through finished field installation, ensuring quality control at every production stage.

This vertical integration approach guarantees that only specified ingredients enter final products, addressing questions about material composition that facility managers increasingly raise during procurement decisions. Third-party analytical chemistry laboratories have tested raw materials and finished goods, with results showing contaminant concentrations below detectable limits.

Climate-controlled prefabrication facilities allow precise assembly of field sections before transport to installation sites, minimizing variables during field construction and ensuring consistent quality regardless of geographic location or weather conditions during installation periods.

The trajectory of synthetic turf development points toward continued integration of advanced safety features with sustainable manufacturing practices. For athletic administrators evaluating surface options, the research emerging from university partnerships offers clear guidance on which technologies deliver measurable protection for the athletes who ultimately depend on these decisions.

The post What Makes Artificial Turf Like AstroTurf Safe? University Research and Independent Testing Reveal Key Factors appeared first on Green Prophet.